1. Home
  2. TITN vs ADCT Comparison

TITN vs ADCT Comparison

Compare TITN & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan Machinery Inc.

TITN

Titan Machinery Inc.

HOLD

Current Price

$19.81

Market Cap

416.9M

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$3.88

Market Cap

484.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TITN
ADCT
Founded
1980
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
416.9M
484.4M
IPO Year
2007
2019

Fundamental Metrics

Financial Performance
Metric
TITN
ADCT
Price
$19.81
$3.88
Analyst Decision
Hold
Strong Buy
Analyst Count
4
4
Target Price
$20.50
$7.75
AVG Volume (30 Days)
177.0K
641.0K
Earning Date
05-21-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.86
EPS
N/A
N/A
Revenue
$2,427,107,000.00
$81,357,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.75
$66.49
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.85
52 Week Low
$13.21
$1.13
52 Week High
$21.75
$4.98

Technical Indicators

Market Signals
Indicator
TITN
ADCT
Relative Strength Index (RSI) 66.54 49.84
Support Level $18.73 $3.41
Resistance Level $20.65 $4.71
Average True Range (ATR) 0.71 0.21
MACD 0.46 0.01
Stochastic Oscillator 87.47 66.92

Price Performance

Historical Comparison
TITN
ADCT

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: